NCI’s Tech-Based Therapy Helps Patients Battle HPV-Linked Respiratory Disease
Dr. Clint Allen, Senior Investigator, Center for Cancer Research, NCI and Dr. Scott Norberg, Associate Research Physician, Center for Cancer Research, NCI
The National Cancer Institute is exploring a new tech-based treatment to help patients overcome a severe breathing disorder caused by the Human Papilloma Virus.
Leaders from the agency’s Center for Cancer Research — Dr. Clint Allen, a senior investigator, and Dr. Scott Norberg, an associate research physician — join us to discuss the findings from their recent study on the Recurrent Respiratory Papillomatosis, which can cause damage to the vocal cords and block airways, making it hard to breathe.
Allen and Norberg shared details about the therapy, which uses a gorilla adenovirus based-technology to target the infection.
-
Dr. Clint Allen Senior Investigator, Center for Cancer Research, NCI -
Dr. Scott Norberg Associate Research Physician, Center for Cancer Research, NCI
-
EHR Rollout On Track, VA Deputy Secretary Tells Congress
VA officials told Congress the renewed EHR rollout is on schedule and exceeding expectations as deployments expand across the country.
3m read -
How Federal Health Agencies Are Scaling AI Pilots
NIAID’s platform and NIH’s Bio Genesis Mission reflect a broader push to move AI into mission workflows and accelerate biomedical discovery.
-
Federal Health Agencies Are Using AI to Improve Care
Federal health leaders are deploying AI for nursing home safety, virtual clinical training and more connected pediatric care.
4m read -
Faster AI Adoption Starts With Smarter Federal Acquisition
NIH, HHS and industry leaders outline ways to speed procurement, preserve human oversight and close the gap between AI pilots and production.
2m read
